CM-Patient-landing-page-image

DecisionDx-Melanoma is a prognostic test for patients diagnosed with Stage I – III cutaneous melanoma. Our test looks at your tumor biology to predict the risk of your melanoma spreading or coming back.

Download the patient discussion guide to facilitate a conversation with your healthcare to determine if DecisionDx-Melanoma is right for you.

Be your own advocate: Morgan England, stage III melanoma survivor, shares her story

With DecisionDx-Melanoma, you and your doctor can make informed decisions about: 

Artboard 121@4x
 
Treatment
  
Artboard 140@4x
Follow-up appointments with your dermatologist
Artboard 124@4x
Additional visits with other specialties (referrals)
Artboard 126@4x
Surgical procedures such as a sentinel lymph node biopsy

Hear how physicians use DecisionDx-Melanoma

Why DecisionDx-Melanoma?

CM Patient Web Graphic-v7

Talk to your doctor to determine if the DecisionDx-Melanoma test is right for you.
References
  1. Berger et al. CMRO. 2016.
  2. Farberg et al. J Drugs Derm. 2017.  
  3. Dillon et al. CMRO. 2022.
  4. Bailey et al.  JCO PO. 2023. 
  5. Dhillon et al. Arch Dermatol Res. 2023.